Latest Articles

Publication Date
Epidemiology, Risk Factors, Diagnosis, and Comorbidities of Endometriosis: An Umbrella Review.

Background: Endometriosis is a chronic estrogen-dependent inflammatory disease estimated to affect up to 190 million women of reproductive age worldwide based on clinical and population-based estimates, although only 22.3 million …

Published: June 12, 2026, midnight
The role of IL-33/ST2 signaling in female reproductive diseases.

Female reproductive tissues repeatedly undergo controlled inflammation, immune adaptation, and tissue repair. Interleukin-33 (IL-33) and its receptor suppression of tumorigenicity 2 (ST2) sit at the center of these processes, but …

Published: June 12, 2026, midnight
Ultrasonographic features and ovarian reserve in ovarian endometrioma: Implications for risk stratification.

To investigate the association between ultrasonographic features of ovarian endometrioma (OMA) and diminished ovarian reserve, and to evaluate the predictive value of these ultrasound markers.

Published: June 12, 2026, midnight
Soroptimist SVG signs MOU to improve health for Girls and Women - SearchLight.vc

Soroptimist SVG signs MOU to improve health for Girls and Women SearchLight.vc

Published: June 11, 2026, 7:04 p.m.
Cyclana Bio Is Exploring the Extracellular Matrix to Treat Endometriosis - Inside Precision Medicine

Cyclana Bio Is Exploring the Extracellular Matrix to Treat Endometriosis Inside Precision Medicine

Published: June 11, 2026, 6:50 p.m.
Incyte’s POD1UM-204 Endometrial Cancer Study Wraps Up, Setting the Stage for Key Retifanlimab Data - TipRanks

Incyte’s POD1UM-204 Endometrial Cancer Study Wraps Up, Setting the Stage for Key Retifanlimab Data TipRanks

Published: June 11, 2026, 4:35 p.m.
Lotus Leaf Tea is Believed to Prevent Cysts to PCOS in Women - VOI.id

Lotus Leaf Tea is Believed to Prevent Cysts to PCOS in Women VOI.id

Published: June 11, 2026, 4:05 p.m.
Lotus Leaf Tea is Believed to Prevent Cysts to PCOS in Women - VOI.ID

Lotus Leaf Tea is Believed to Prevent Cysts to PCOS in Women VOI.ID

Published: June 11, 2026, 4:05 p.m.
Medicus Pharma Submits Ind Application for PRECISION-E2 Phase 2A Study of Teverelix in Endometriosis in United Arab Emirates - marketscreener.com

Medicus Pharma Submits Ind Application for PRECISION-E2 Phase 2A Study of Teverelix in Endometriosis in United Arab Emirates marketscreener.com

Published: June 11, 2026, 1:52 p.m.
Medicus Pharma Ltd. Submits IND Application for Innovative PRECISION-E2 Phase 2a Clinical Trial in Endometriosis - Quiver Quantitative

Medicus Pharma Ltd. Submits IND Application for Innovative PRECISION-E2 Phase 2a Clinical Trial in Endometriosis Quiver Quantitative

Published: June 11, 2026, 11:41 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!